Non-Alcoholic Fatty Liver Disease and Prediabetes

被引:0
|
作者
Mansour-Ghanaei, Fariborz [1 ]
Jafarinejad, Alireza [1 ]
Roshan, Zahra Atrkar [1 ]
Khosravi, Hadi [1 ]
Hassankhani, Amir [2 ]
Maafi, Alireza Amir [2 ]
机构
[1] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran
[2] Guilan Univ Med Sci, Student Res Ctr, Rasht, Iran
来源
关键词
Non-alcoholic Fatty Liver Disease; Prediabetes; Ultrasonography;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. The simultaneous occurrence of NAFLD and type 2 diabetes is common, however, few studies on the prevalence of NAFLD in prediabetic patients have been performed. Therefore, the aim of this study was to determine the prevalence of NAFLD by sonography in prediabetic patients and to compare the prevalence of NAFLD between prediabetic patients and normal population. METHODS: In this cross-sectional study, 191 consecutive prediabetic patients who were referred to the internal medicine clinic in the Razi Referral Hospital of Rasht, Iran, were compared with 191 healthy controls. Diagnosis of prediabetes was based on abnormal oral glucose tolerance test or fasting plasma glucose. Both groups underwent ultrasonography for the assessment of NAFLD and data was analyzed by Student's t test and Chi-square test. RESULTS: Patient population was between 20 and 70 years old and the mean age of participants was 41.04 +/- 12.66 years. Prediabetic group had 71(37.1%) males while healthy group had 84(43.9%) males. Of the 382 subjects, 142 (37.2%) had evidence of NAFLD on ultrasound examination of which 93(65.4%) were prediaibetics (P=0.001). CONCLUSION: We show that the prevalence of NAFLD in prediabetic patients is higher than healthy individual.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [41] An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (08) : 759 - 772
  • [42] Surgical Treatment of Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease
    Weiner, R. A.
    DIGESTIVE DISEASES, 2010, 28 (01) : 274 - 279
  • [43] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [44] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [45] Non-alcoholic fatty liver disease in children
    Chaturvedi, Kanupriya
    Vohra, Pankaj
    INDIAN PEDIATRICS, 2012, 49 (09) : 757 - 758
  • [46] Non-alcoholic fatty liver disease and diabetes
    Reyes-Garcia, Rebeca
    Rozas-Moreno, Pedro
    Julio Llamoza-Torres, Camilo
    Mezquita-Raya, Pedro
    MEDICINA CLINICA, 2017, 148 (01): : 33 - 38
  • [47] Mitochondria in non-alcoholic fatty liver disease
    Prip-Buus, C.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 : 53 - 53
  • [48] Hyperuricemia in non-alcoholic fatty liver disease
    Dogru, T.
    Genc, H.
    Tapan, S.
    Bagci, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 1042 - 1043
  • [49] CEUS and Fibroscan in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Cocciolillo, Sila
    Parruti, Giustino
    Marzio, Leonardo
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 496 - 503
  • [50] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223